DocWire News Editors

DocwireNews

An international group of researchers examined whether microbiota configuration prior to hematopoietic cell transplantation (HCT) could determine outcomes after transplant, including survival, relapse, infections, and graft-versus-host disease (GVHD). Their presentation at the ASH annual meeting, microbiota configuration had previously been studied only at single institutions and only in the weeks following HCT.According to Jonathan U. Peled, MD, PhD, of the Adult Bone Marrow Transplant Service at Memorial Sloan Kettering Cancer Center, and colleagues, patients at four institutions on three continents presented with microbiota configurations that were similar and distinct from those of healthy individuals.&ldquo;Severe microbiota injury is a common event whose development begins before allograft infusion, and pre-HCT microbiota injury predicts poor overall survival,&rdquo; he added.The researchers collected 1,922 stool samples about weekly from 991 adult patients receiving allogeneic HCT at two transplant centers in the United States, one in Europe, and one in Japan. The patients had varying underlying diagnoses, sources of donor grafts, conditioning intensities, and methods for GVHD prophylaxis. The samples all were sequenced and analyzed at the same laboratory.According to the findings, patients from all four centers had reduced microbiota diversity before HCT, as compared to healthy volunteers sequenced either by the study researchers or available in a public dataset. Additionally, the differences in samples across geography were very small in magnitude. In the largest cohort, low diversity was associated with exposure to broad-spectrum antibiotics, conditioning intensity, and low calorie intake. Finally, also in the largest cohort, pre-HCT diversity was associated with survival.The researchers concluded that, together, the results reveal a &ldquo;window of opportunity,&rdquo; and they encouraged healthcare teams to evaluate microbiota injury before HCT to determine comorbidities and select appropriate treatments (such as antibiotics, prophylaxis for GVHD, and conditioning regimens), adding that knowledge before HCT could inform strategies to remediate or prevent microbiota injury.

Jordana Jampel

Positive Preliminary Results From Phase 1 Trial of Dopaminergic Neuron Graft for Parkinson’s Disease

Dementia

Bradley Warady, MD

Joel M. Topf, MD, FACP

2025 Hume Award Winner Is Dedicated to Children’s Care

NKF Spring Clinical Meetings 2025

Distant Brain Metastases in Cutaneous Melanoma May Be Mitigated With Multiple Pathway Inhibitors

Melanoma

Latest News

International Study: Microbiota Injury Before HCT Is Prevalent and Predicts Poor Survival

ASH Annual Meeting 2018

An international group of researchers examined whether microbiota configuration prior to hematopoietic cell transplantation (HCT) could determine outcomes after transplant, ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe